Market Tracker

12/17 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.44 +0.08 / +5.88%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.44 +0.0002 / +0.01%
 
Volume: 28.1K

Today’s Trading

Previous close1.36
Today’s open1.36
Day’s range1.36 - 1.45
Volume1,006,617
Average volume (3 months)1,015,552
Market cap$247.6M
Dividend yield--
Data as of 3:59pm ET, 12/17/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-36.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.46+7.82%
ALIMAlimera Sciences Inc-0.07-1.28%
ADMSAdamas Pharmaceutica...+0.49+3.47%
ACRXAcelRx Pharmaceutica...+0.30+5.15%
Data as of 4:00pm ET, 12/17/2014

Financials

Next reporting dateMarch 6, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts